Melbourne, Australia; 5 May 2020: Starpharma (ASX: SPL, OTCQX: SPHRY) has been invited to present today at the Macquarie Australia Conference. Due to COVID-19, the Macquarie Australia Conference will be a virtual conference for registered institutional investors. The event will provide international and domestic institutions with the opportunity to hear from a range of invited Australian companies over three days. Starpharma is one of a handful of companies in the pharmaceutical/biotech and healthcare industries to be presenting during the conference.

The Macquarie Australia Conference is a leading investment event in Australia and attracts more than 800 investors from around the world, including Asia, Europe and North America.

A copy of the slides will be made available on the Starpharma website at http://www.starpharma.com/. The slides are an abridged version of the Company’s full corporate presentation.

Download ASX announcement: Starpharma presents at Macquarie Australia Conference (pdf, 49kb)

Download presentation slides: Starpharma presentation slides - Macquarie Australia Conference (pdf, 2MB)